QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant (ReGIFT)

What is the purpose of this trial?

The purpose of this trial is to evaluate the reduction in incidence and severity of delayed graft function with kidney allografts from donors >45 years after brain death (DBD).

Participation Guidelines

Ages: 18 years and older

Gender: Both

Quark Pharmaceuticals

Dates: 01/01/2016 - 06/30/2019

Last Updated: 02/22/2018

Study HIC#: 1510016593

Get Involved

For more information about this study, contact:
Kristine Tyc
+1 203-737-4697

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image


Sanjay Kulkarni

Principal Investigator